Brandon Keith Nance, DO | |
24 Joliet St, Dyer, IN 46311-1705 | |
(219) 865-2141 | |
(219) 865-2141 |
Full Name | Brandon Keith Nance |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 24 Joliet St, Dyer, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134625148 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 02006306A (Indiana) | Secondary |
208M00000X | Hospitalist | 02006306A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brandon Keith Nance, DO 1720 S Michigan Ave, Chicago, IL 60616-1465 Ph: () - | Brandon Keith Nance, DO 24 Joliet St, Dyer, IN 46311-1705 Ph: (219) 865-2141 |
News Archive
A gel that creates a watertight seal to close surgical wounds provides a significant advance in the treatment of patients following spinal procedures, effectively sealing spinal wounds 100 percent of the time, a national multicenter randomized study led by researchers at UC Davis has found.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
Genzyme Corporation and Arecor Limited today signed an agreement providing for extensive collaboration on developing advanced formulations for protein therapeutics. The agreement provides for a close working relationship between Genzyme and Arecor in developing stable, high strength formulations of labile biomolecules. This agreement is the result of a two year working relationship where Arecor has demonstrated their technologies offer an improvement over conventional approaches in protein formulation.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today participated in the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells - a process that potentially could be used against a range of chronic viral diseases.
› Verified 2 days ago
Jeannie Boram Ur, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-933-2288 | |
Dr. Harold Leroy Rahming, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 24 Joliet St, Dyer, IN 46311 Phone: 219-865-2141 Fax: 219-933-2288 |